Linde India: The Supreme Court rejected Linde India's appeal against a Securities and Exchange Board of India (SEBI) ...

Among patients with limited-stage small cell lung cancer, the benefits of consolidation Imfinzi were seen across a number of ...

AstraZeneca Pharma India has received approval from the CDSO for the import, sale, and distribution of Durvalumab.

Benchmark equity indices closed flat on Tuesday after hitting record highs. Nifty50 surpassed 26,000 and Sensex crossed ...

Astrazeneca Pharma India has received CDSO's (Central Drugs Standard Control Organisation) nod for the import of Durvalumab ...

The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages ...

Indian shares were flat to slightly higher on Tuesday, with metal, oil/gas and power stocks pacing the gainers. The benchmark ...

Oct. 11, 2023 — Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options. A recent research study identified the ...

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...

Research presented at ESMO 2024 could have practice-changing implications for breast, gastrointestinal, genitourinary, and gynecologic cancers.

The recent ESMO 2024 data highlighted significant advancements in immunotherapy. Check out the results from Merck, BMY, ...

While none of the experimental combinations met efficacy targets, durvalumab with monalizumab and ceralasertib showed ...